Literature DB >> 20837311

Pediatric neuro-Behçet's disease responsive to adalimumab.

Angela Byun Robinson1, William B Gallentine, C Egla Rabinovich.   

Abstract

Neurologic manifestations of Behçet's disease (neuro-Behçet's disease) are uncommon, but may cause patients significant morbidity and mortality. Neuro-Behçet's disease is chronic and may be refractory to treatment. We report on a 12-year-old girl with neuro-Behçet's disease that responded to standard doses of subcutaneous adalimumab.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20837311     DOI： 10.1016/j.pediatrneurol.2010.04.021

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN： 0887-8994            Impact factor:   3.372


  9 in total

Review 1.  The development and assessment of biological treatments for children.

Authors:  Eve M D Smith; Helen E Foster; Michael W Beresford
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 2.  Clinical Manifestations and Management of Pediatric Behçet's Disease.

Authors:  Ya-Chiao Hu; Bor-Luen Chiang; Yao-Hsu Yang
Journal:  Clin Rev Allergy Immunol       Date:  2021-10       Impact factor: 8.667

Review 3.  A young girl with refractory intestinal Behçet's disease: a case report and review of literatures on pediatric cases who received an anti-tumor necrosis factor agent.

Authors:  Shojiro Watanabe; Tomomi Aizawa-Yashiro; Kazushi Tsuruga; Manabu Kinjo; Etsuro Ito; Hiroshi Tanaka
Journal:  Rheumatol Int       Date:  2012-12-25       Impact factor: 2.631

Review 4.  Behçet's Disease and Nervous System Involvement.

Authors:  Murat Kürtüncü; Erdem Tüzün; Gulsen Akman-Demir
Journal:  Curr Treat Options Neurol       Date:  2016-05       Impact factor: 3.598

Review 5.  Adalimumab in the management of Behçet's disease.

Authors:  Atsuhisa Ueda; Mitsuhiro Takeno; Yoshiaki Ishigatsubo
Journal:  Ther Clin Risk Manag       Date:  2015-04-13       Impact factor: 2.423

Review 6.  Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions.

Authors:  Katherine Anne B Marzan
Journal:  Adolesc Health Med Ther       Date:  2012-06-20

7.  Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.

Authors:  Ya-Chiao Hu; Yao-Hsu Yang; Yu-Tsan Lin; Li-Chieh Wang; Hsin-Hui Yu; Jyh-Hong Lee; Bor-Luen Chiang
Journal:  BMC Pediatr       Date:  2019-07-11       Impact factor: 2.125

Review 8.  Recent understanding on diagnosis and management of central nervous system vasculitis in children.

Authors:  Ludovico Iannetti; Roberta Zito; Simone Bruschi; Laura Papetti; Fiorenza Ulgiati; Francesco Nicita; Francesca Del Balzo; Alberto Spalice
Journal:  Clin Dev Immunol       Date:  2012-09-12

Review 9.  Neuro-Behçet's disease in childhood: a focus on the neuro-ophthalmological features.

Authors:  Paolo Mora; Chiara Menozzi; Jelka G Orsoni; Pierangela Rubino; Livia Ruffini; Arturo Carta
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.